Generic drugs remain twice as expensive in Switzerland
Drug prices in Switzerland remain higher than in other major European markets, especially when it comes to generic drugs, which are twice as expensive in Switzerland as elsewhere.
According to figures published Tuesday by the Swiss pharma industry association InterpharmaExternal link and the umbrella group for health insurers SantéSuisseExternal link, the difference in the price of patented drugs in Switzerland compared to elsewhere is 7%, down from 9% last year.
This is thanks in part to more favourable exchange rates, as well as regular price controls by the Federal Office of Public Health (FOPH), according to the groups. The savings due to lower prices are estimated to be some CHF325 million ($323 million).
However, it’s a different story for generic drugs, which are twice as expensive in Switzerland than in similar markets. The Swiss also tend to buy less generics, which represent 23% of volume and 18% of sales. In the United Kingdom, as a comparison, generics represent 85% of volume and 38% of sales.
For example, in Switzerland a pack of the patented painkiller Dafalgan costs CHF6.95 more than the generic version Paracetamol. Despite the potential savings, Dafalgan remains more popular: 900,000 packages were sold last year for a total of CHF23.1 million, compared to only 65,000 packs of Paracetamol sold at CHF1.2 million.
Despite the discrepancies, buying generics still represent savings compared to patented versions, SantéSuisse says.
This is the tenth edition of the report, which compares prices for 250 of the best-selling drugs in Switzerland to those in Belgium, Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden.
Popular Stories
More
Foreign affairs
What Trump’s return or a new Harris administration would mean for Switzerland
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Is reforming the Swiss pension system still possible, and if so, how?
Solutions still need to be found to meet the challenge of an ageing population and to improve the pensions of low-paid workers, the majority of whom are women.
This content was published on
Czech President Petr Pavel and his wife, Eva Pavlova, arrived in Switzerland on Tuesday at the start of a two-day state visit.
Study shows proliferation of non-native plants is driver of insect invasions
This content was published on
A global study has revealed that insect invasions are being driven by the proliferation of non-native plants. This can can massively disrupt ecological processes, often leading to serious economic impacts.
Swiss set record for world’s longest hyperloop test
This content was published on
Swiss scientists have established a record for the longest-ever hyperloop journey at a facility in Lausanne, Switzerland.
This content was published on
The Swiss army wants to purchase new German armoured howitzers to replace its existing artillery system which has been in operation for over 50 years.
Poll suggests Donald Trump has many fans in Switzerland
This content was published on
Around a quarter of Swiss citizens would vote for Donald Trump if they had the chance, according to a recent poll. This percentage is higher than in many other European countries.
Swiss court rejects special assistance for student with disabilities
This content was published on
The Swiss Federal Court has rejected an application for special assistance from a student with disabilities at the federal technology institute ETH Zurich.
Police arrest 15 drug dealers in Verbier in southern Switzerland
This content was published on
Swiss and French police have arrested 15 suspected drug dealers operating in the mountain resort of Verbier in southern Switzerland.
New European space tech centre in Switzerland launches its first project
This content was published on
The European Space Deep-Tech Innovation Centre (ESDI), launched in collaboration with the Paul Scherrer Institute (PSI), is to be located in the immediate vicinity of the PSI in northern Switzerland.
Swiss Federal Railways launches campaign for safety on public transport
This content was published on
The Swiss Federal Railways is launching a campaign for greater respect and safety on public transport, with posters to go up in stations and on trains starting next week.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Costs of generic drugs and outpatient services targeted
This content was published on
The government wants to cap prices for generic drugs as part of a package of measures to reduce rising health costs in Switzerland.
This content was published on
Switzerland could save millions of francs by prescribing low-priced biotech drug copies, known as biosimilars, instead of expensive biologicals.
Swiss bend rules to provide patients with affordable treatment
This content was published on
Despite being a global hub for pharma companies, Switzerland is going to extraordinary lengths to source cheap generic drugs for Hepatitis C patients.
Generic drugs in Switzerland cost twice as much as in Europe
This content was published on
The price of generic drugs in Switzerland in 2017 was 52% higher than the average of nine other European countries, says a study.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.